Skip to main content

Screening Biochemical Markers for the Prevention of Coronary Heart Disease

  • Chapter
  • First Online:
Book cover Chemistry for Sustainable Development
  • 1140 Accesses

Abstract

Coronary heart disease (CHD) is among one of the major causes of deaths in Mauritius. It is important to screen biochemical markers, amongst other clinical and para-clinical tests, in view of the prevention of the disease. The study consisted of screening a random sample of 300 employees for total cholesterol above the desirable range (>5.17 mmol/l). A second fasting blood test was performed in those who had high total cholesterol. The lipid profile was performed using commercially available kits. The Total Cholesterol to High Density Lipoprotein Cholesterol ratio was calculated for identification of those at risk of CHD.

The findings showed an important prevalence of blood lipid abnormalities in the studied population, thus highlighting the need for screening for abnormal levels of these biochemical markers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. World Health Organization (2004) Global burden of coronary heart disease. In: Mackay J, Mensah G (eds) The atlas of heart disease and stroke, Part 3: the burden. World Health Organization, Geneva. http://www.who.int/cardiovascular_diseases/resources/atlas/en/. Accessed 8 Sept 2010

  2. World Health Organization (2005) Preventing chronic diseases: a vital investment. World Health Organization, Geneva. http://www.who.int/. Accessed 8 Sept 2010

  3. Brewer HB (2004) A new dawn in the treatment of Dyslipidaemia: cardiovascular risk reduction through emerging science and proven clinical results. Am Heart J 148:S1–S2

    Article  Google Scholar 

  4. Gupta R, Gupta HP, Kumar N, Joshi AK, Gupta VP (1994) Lipoprotein lipids and the prevalence of hyperlipidaemia in rural India. J Cardiovasc Risk 1:179–184

    CAS  Google Scholar 

  5. Rafiei M, Boshtam M, Sarraf-Zadegan N (1999) Lipid profiles in the Isfahan population: an Isfahan cardiovascular disease risk factor survey, 1994. East Mediterr Health J 5:766–777

    CAS  Google Scholar 

  6. Foucan L, Kangambega P, Koumavi Ekouevi D, Rozet JE, Bangou-Brédent J (2000) Lipid profile in an adult population in Guadeloupe. Diabetes Metab 26:473–480

    CAS  Google Scholar 

  7. Yarzebski J, Spencer F, Goldberg RJ, Lessard D, Gore JM (2001) Temporal trends (1986–1997) in cholesterol level assessment and management practices in patients with acute myocardial infarction. Arch Intern Med 161:1521–1528

    Article  CAS  Google Scholar 

  8. Wang TD, Chen WJ, Chien KL, Su SS, Hsu HC, Chen MF, Liau CS, Lee YT (2001) Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a chinese population. Am J Cardiol 88:737–743

    Article  CAS  Google Scholar 

  9. American Association of Clinical Endocrinologist (AACE) (2002) AACE lipid guidelines. Endocr Pract 6:4–52

    Google Scholar 

  10. Eghan BA Jr, Acheampong JW (2003) Dyslipidaemia in outpatients at General Hospital in Kumasi, Ghana: cross-sectional study. Croat Med J 44:576–578

    Google Scholar 

  11. National Cholesterol Education Program Expert Panel (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high cholesterol in adults (Adults Treatment Panel III). J Am Med Assoc 285:2486–2497

    Article  Google Scholar 

  12. Rifai N, Bachorik PS, Albers JJ (1999) Lipids, lipoproteins & apolipoproteins. In: Burtis CA, Ashwood ER (eds) Tietz textbook of clinical chemistry, 3rd edn. Saunders, Philadelphia, pp 809–861

    Google Scholar 

  13. World Health Organization (2010) Health systems financing: the path to universal coverage. The world health report 2010. World Health Organization, Geneva. http://www.who.int/whr/2010/en/index.html. Accessed 8 Sept 2010

  14. Ministry of Health and Quality of Life, Republic of Mauritius (2009) The trends in diabetes and cardiovascular disease risk in Mauritius. Mauritius non communicable diseases survey report

    Google Scholar 

  15. United States Preventive Services Task Force (2008) Screening for lipid disorders in adults: recommendation statement. http://www.uspreventiveservicestaskforce.org/uspstf08/lipid/lipidrs.htm. Accessed 8 Sept 2010

  16. United States Preventive Services Task Force (2002) Screening for lipid disorders in adults: recommendations and rationale. Internet J Intern Med 3(2). http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijim/vol3n2/lipid.xml. Accessed 8 Sept 2010

  17. Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, Stewart S (2008) Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 371:915–922

    Article  Google Scholar 

  18. Cheng J, Zhao D, Zeng Z, Critchley JA, Liu J, Wang W, Sun J, Capewell S (2009) The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing (1999–2010). BMC Public Health 9:30

    Article  Google Scholar 

  19. Gupta R, Kaul V, Bhagat N, Agrawal M, Gupta VP, Misra A, Vikram NK (2008) Trends in prevalence of coronary risk factors in an urban Indian population: Jaipur Heart Watch-4. Indian Heart J 156:112–119

    Google Scholar 

  20. Ghandehari H, Kamal-Bahl S, Wong ND (2008) Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003–2004. Am Heart J 156:112–119

    Article  CAS  Google Scholar 

  21. Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J, Dagenais GR, Despres JP (2001) Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men. Arch Intern Med 161:2685–2692

    Article  CAS  Google Scholar 

  22. Bersot TP, Pépin GM, Mahley RW (2003) Risk determination in populations characterised by low levels of high-density lipoprotein cholesterol. Am Heart J 146:1052–1060

    Article  CAS  Google Scholar 

  23. Natarajan S, Glick H, Criqui M, Horowitz D, Lipsitz SR, Kinosian B (2003) Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med 25:50–57

    Article  Google Scholar 

  24. Centers for Disease Control. Heart Disease (On line). Available at http://www.cdc.gov/Features/WorldHeartDay/. Accessed 30 Sept 2010

Download references

Acknowledgements

The authors are thankful to the staff of the Department of Medicine, University of Mauritius for technical support provided.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marie Chan Sun .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Albana, D., Sun, M.C. (2012). Screening Biochemical Markers for the Prevention of Coronary Heart Disease. In: Gupta Bhowon, M., Jhaumeer-Laulloo, S., Li Kam Wah, H., Ramasami, P. (eds) Chemistry for Sustainable Development. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-8650-1_31

Download citation

Publish with us

Policies and ethics